{"id":"W2158310952","doi":"10.1016/s0140-6736(02)09096-7","title":"Drug development for neglected diseases: a deficient market and a public-health policy failure","year":2002,"lang":"en","type":"review","venue":"The Lancet","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":882,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Incentive; Private sector; Public health; Pharmaceutical industry; Drug development; Developing country; Business; Market failure; Medicine; Disease; Neglected tropical diseases; Agency (philosophy); Economic growth; Public economics; Drug; Economics; Pharmacology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.157997367515106,"score_gpt":0.3480298722680117,"score_spread":0.1900325047529057,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}